Immunoglobulin kappa variable 1-32 (IGKV1-32)

Immunoglobulin kappa variable 1-32 (IGKV1-32) is a member of the immunoglobulin kappa light chain variable gene family, located in the immunoglobulin kappa locus in humans[4]. It encodes the variable domain of the kappa light chain, which combines with the immunoglobulin heavy chain variable domain to generate antigen specificity in antibodies[3]. Individual V-region segments are selected and rearranged during B-cell development through V(D)J recombination, contributing to the diversity of the antibody repertoire[3]. IGKV1-32 is not itself a functional protein or direct therapeutic target; rather, it is one of many possible variable gene segments that can be incorporated into antibodies. Some human immunoglobulin variable gene segments are pseudogenes (not functional). There is scant evidence of IGKV1-32 as an independent entity in drug targeting, disease diagnosis, or therapy. The correct gene may be "immunoglobulin kappa variable 1D-32 (pseudogene)" or a similar V-region segment; IGKV1-32 is not recognized as a standard therapeutic target or druggable protein[1][4]. Variable gene segments like IGKV1-32 are not independently associated with diseases, but disruption or abnormal usage of immunoglobulin loci, as a family, can play roles in cancer—e.g., B cell malignancies[3]. The variable region genes themselves are not direct drug targets or known to interact with drugs, and have no independent mechanism of action, as they encode the variable regions of antibodies used for antigen binding. Individual V-region segments like IGKV1-32 are not established biomarkers. There are no specific safety or therapeutic concerns for a single immunoglobulin V-region gene segment. There is very limited information about "IGKV1-32" in major protein or gene databases, and it is possible that the actual gene is a pseudogene or rarely used allele, or that the number is a minor variant or less-commonly annotated segment[1][4]. IGKV gene segments are not drug targets themselves, but the antibodies they help produce are central to immune defense and the action of many immunotherapies.

Other names

Immunoglobulin kappa V region 1-32IGKV1D-32IGK V1-32